Ozempic may reduce risks of mental health deterioration – study
Kyiv • UNN
A study in The Lancet Psychiatry showed a positive effect of semaglutide on mental health. Risks of addictions and anxiety disorders almost halved.

A new study has shown that semaglutide-based drugs, including Ozempic and Wegovy, can have a positive impact not only on physical but also on mental health. This includes reducing the risks of worsening depression, anxiety, and addictions. Bloomberg reports this, writes UNN.
Details
According to a study published in The Lancet Psychiatry, the risk of worsening depression decreased by 44%, anxiety by 38%, and addictions by 47%. Scientists analyzed data from almost 95,000 people with diabetes or obesity and mental disorders.
Further research needed
Scientists consider the results promising enough to initiate clinical trials to test the effectiveness of these drugs in treating mental disorders.
New weight loss drug helped patients lose up to 20% of weight - study24.06.25, 10:05 • 2912 views
Better mental health is generally a consequence of better physical health, and since the 1880s we have known that diabetes is associated with depression
At the same time, experts emphasize that these drugs are unlikely to become an independent means of treating depression or anxiety, but can play an auxiliary role.
Slimming with Ozempic: less praiseworthy than dieting and sports03.04.25, 20:26 • 12891 view